NCT06609668View on ClinicalTrials.gov

Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

RecruitingOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Giant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
Interventions
BIOLOGICAL

Additional blood samples

"* 1 dry tube (5 mL)~* 1 EDTA tube (6 mL)~Performed at inclusion (before any glucocorticoid and/or immunosuppressive treatment) and at follow-up visit (3 months after inclusion)"

Trial Locations (1)

21000

RECRUITING

CHU Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER